Welcome to precisionFDA

Welcome to PrecisionFDA

A community platform for NGS assay evaluation and regulatory science exploration.

April 2017 Expert Spotlight:
Adam resnick phd d3bcenter headshot
My Challenge to the PrecisionFDA Community


Adam Resnick, PhD
Children's Hospital of Philadelphia

1. How might the pediatric cancer and rare disease community best engage the precisionFDA NGS assay development community and sponsor the further development of a sustainable compete-to-share ecosystem for collaborative discovery on behalf children?

2. How can the precisionFDA bioinformatics community be better empowered to partner with the pediatric cancer and rare disease community through a shared economy of accessible data and a shared interest in new models of attribution and/or reproducibility of results?

About PrecisionFDA
Community Participants
NIST
Garvan
Baylor College of Medicine
Roche
GeneDx
Human Longevity Inc.
NIH
US House of Representatives
Sequenom
23andMe
PharmGKB
Emory Genetics Lab
Centers for Disease Control and Prevention
Personalis
American Heart Association
White House Office of Science and Technology Policy
Macrogen
Seracare
Intel
Illumina
DNAnexus
Natera
Broad Institute
Counsyl
Crystal Genetics

Dr. Russ Altman
Dr. Euan Ashley
Hans Nelsen
Rachel Goldfeder
Dr. Mark Wright
Dr. Dennis P. Wall
Dr. Snehit Prabhu
Dr. Lester Carter
Mark Woon
Dr. Teri Klein
Dr. Peter Tonellato

The comparison framework uses open-source software by Real Time Genomics
Learn more about precisionFDA
Feedback Feedback